| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 9758 | 2021 |
| The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease … S Alatab, SG Sepanlou, K Ikuta, H Vahedi, C Bisignano, S Safiri, ... The Lancet gastroenterology & hepatology 5 (1), 17-30, 2020 | 2102 | 2020 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1478 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 661 | 2022 |
| Curcumin: A new candidate for melanoma therapy? H Mirzaei, G Naseri, R Rezaee, M Mohammadi, Z Banikazemi, ... International journal of cancer 139 (8), 1683-1695, 2016 | 286 | 2016 |
| Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? E Mianehsaz, HR Mirzaei, M Mahjoubin-Tehran, A Rezaee, ... Stem cell research & therapy 10, 1-13, 2019 | 261 | 2019 |
| MicroRNA: A novel target of curcumin in cancer therapy H Mirzaei, A Masoudifar, A Sahebkar, N Zare, J Sadri Nahand, B Rashidi, ... Journal of cellular physiology 233 (4), 3004-3015, 2018 | 260 | 2018 |
| Glioblastoma: exosome and microRNA as novel diagnosis biomarkers L Saadatpour, E Fadaee, S Fadaei, R Nassiri Mansour, M Mohammadi, ... Cancer gene therapy 23 (12), 415-418, 2016 | 256 | 2016 |
| Chimeric antigen receptors T cell therapy in solid tumor: challenges and clinical applications HR Mirzaei, A Rodriguez, J Shepphird, CE Brown, B Badie Frontiers in immunology 8, 1850, 2017 | 226 | 2017 |
| Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: a review J Sadri Nahand, M Moghoofei, A Salmaninejad, Z Bahmanpour, ... International journal of cancer 146 (2), 305-320, 2020 | 211 | 2020 |
| MicroRNA: relevance to stroke diagnosis, prognosis, and therapy H Mirzaei, F Momeni, L Saadatpour, A Sahebkar, M Goodarzi, ... Journal of cellular physiology 233 (2), 856-865, 2018 | 200 | 2018 |
| MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma H Mirzaei, S Gholamin, S Shahidsales, A Sahebkar, MR Jaafari, ... European journal of cancer 53, 25-32, 2016 | 191 | 2016 |
| Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 NC Galles, PY Liu, RL Updike, N Fullman, J Nguyen, S Rolfe, AN Sbarra, ... The Lancet 398 (10299), 503-521, 2021 | 166 | 2021 |
| Diagnostic and therapeutic potential of exosomes in cancer: the beginning of a new tale? H Mirzaei, A Sahebkar, MR Jaafari, M Goodarzi, HR Mirzaei Journal of cellular physiology 232 (12), 3251-3260, 2017 | 163 | 2017 |
| Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers H Reza Mirzaei, A Sahebkar, M Mohammadi, R Yari, H Salehi, ... Current pharmaceutical design 22 (34), 5257-5269, 2016 | 157 | 2016 |
| Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role P Naeli, MH Pourhanifeh, MR Karimzadeh, Z Shabaninejad, ... Critical reviews in oncology/hematology 145, 102854, 2020 | 154 | 2020 |
| Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy R Shafabakhsh, MH Pourhanifeh, HR Mirzaei, A Sahebkar, Z Asemi, ... Pharmacological research 147, 104353, 2019 | 148 | 2019 |
| Epi-drugs and Epi-miRs: moving beyond current cancer therapies R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ... Current cancer drug targets 16 (9), 773-788, 2016 | 138 | 2016 |
| Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy HR Mirzaei, H Mirzaei, SY Lee, J Hadjati, BG Till Cancer letters 380 (2), 413-423, 2016 | 138 | 2016 |
| Therapeutic application of multipotent stem cells H Mirzaei, A Sahebkar, LS Sichani, A Moridikia, S Nazari, J Sadri Nahand, ... Journal of cellular physiology 233 (4), 2815-2823, 2018 | 135 | 2018 |
Hamed MirzaeiKashan University of Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa kaums.ac.ir
